{
    "nct_id": "NCT06517901",
    "official_title": "MRI-targeted Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer",
    "inclusion_criteria": "* Men undergoing prostate biopsy (either transrectal or transperineal) for suspected prostate cancer as part of their regular medical care\n* Must be eligible to undergo both prostate biopsy procedure (cognitive or fusion)\n* Men undergoing their first prostate biopsy procedure or with no previous prostate biopsy within 3 years\n* Pre-biopsy mp-MRI of prostate with one or more lesions classified as PIRADS 3-5\n* Largest dimension of any lesion on mp-MRI to be ≤ 2 cm\n* Prostate-specific antigen level ≤ 20 ng/mL and/or abnormal digital rectal examination\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* mp-MRI detected lesions that are > 2 cm\n* History of prostate biopsy within 3 years\n* Previous diagnosis of prostate cancer\n* Contraindications to prostate biopsy (eg, fever, evidence of genito-urinary infection, excessive co-morbidities as per treating physician)",
    "miscellaneous_criteria": ""
}